Company Intelligence
Massive Bio
Massive Bio provides enterprise-grade artificial intelligence solutions, delivering specialized Massive Bio Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Country
- United States
- Website
- massivebio.com
- Founded
- 2016
- Stage
- 500 Global
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Massive Bio is an Enterprise Software AI company based in United States, founded in 2016.
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge.
Verified founder profile on Brel: Selin Kurnaz.
What it does
Through the deployment of Massive Bio Platform, Massive Bio provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
Massive Bio Platform
Why It Matters
Massive Bio provides enterprise-grade artificial intelligence solutions, delivering specialized Massive Bio Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Massive Bio
Explore Massive Bio by Massive Bio. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Massive Bio
Industry
Products
Capabilities
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a…
Features
- Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials.
- The company offers tech-enabled services and a big data
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Massive Bio do?
Massive Bio specializes in artificial intelligence, developing Massive Bio Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Massive Bio based and when was it founded?
Massive Bio is based in United States and was founded in 2016.
What are the main products offered by Massive Bio?
The flagship platform from Massive Bio is Massive Bio Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Massive Bio?
Massive Bio primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.